Feline infectious peritonitis (FIP) remains one of the most important and intractable fatal infectious diseases of domestic cats. Despite persistent efforts, there is no efficacious vaccine available. Feline infectious peritonitis virus, the causative agent of FIP, is a mutant virus that arises from the common gastrointestinal infection with feline enteric coronavirus (FECV). Researchers will construct, validate and test a novel orally delivered vaccine against FECV. If successful, this vaccine will control pervasive FECV infection in shelters and other multi-cat environments, while also protecting individual cats against the emergence of mutant viruses that cause FIP.
Grant amount awarded
Colorado State University
Dean, Gregg A. Dean DVM, PhD, DACVP